This brand name is authorized in Ecuador
The drug OMEFAST contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Omeprazole
UNII KG60484QX9 - OMEPRAZOLE
|
|
Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. |
|
2
Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AH | Antacids with sodium bicarbonate | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 3060-MEN-0221, 369301113 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
